Bonus Material-19_Faiz, Pleural Disease II

Pdf Summary

This comprehensive review by Dr. Saadia Faiz covers advanced concepts in pleural diseases focusing on parapneumonic effusions, malignant pleural effusions (MPE), and other pleural pathologies, designed for pulmonary specialists preparing for the 2025 CHEST Board Review.<br /><br />Parapneumonic effusions, caused by pulmonary infections, constitute about 12% of pleural diseases. They range from simple fluid collections resolving with antibiotics to complicated infections and empyema needing drainage and sometimes surgery. Key management includes early diagnosis, broad-spectrum antibiotics targeting aerobic and anaerobic bacteria, and interventions like chest tube drainage and intrapleural fibrinolytics (tPA/DNase), which have shown to reduce surgical needs and hospital stay. Biomarkers remain inconclusive but pleural fluid analysis with low pH, pus, or positive Gram stain guide treatment decisions. <br /><br />Malignant pleural effusions are the second most common exudates, affecting about 1 million people annually and significantly impacting quality of life. Lung and breast cancers are primary causes; prognosis is poor with median survival 3 to 12 months. Diagnosis hinges on pleural fluid cytology, which is variably sensitive, often supplemented by pleural biopsy and immunohistochemistry for tumor origin identification. Prognostic scoring systems (LENT and PROMISE) help estimate survival. Management is patient-centric focusing on symptom relief and prevention of fluid recurrence via thoracentesis, pleurodesis with agents like talc, and indwelling pleural catheters (IPCs). Recent trials support talc administration via IPC to enhance pleurodesis. Aggressive drainage protocols improve auto-pleurodesis rates without increasing complications.<br /><br />Other pleural conditions discussed include mesothelioma (linked to asbestos exposure), benign asbestos-related pleural reactions, solitary fibrous tumors, pleural lipomas, and rare syndromes such as yellow nail syndrome. The review emphasizes the importance of comprehensive diagnostic workup—including imaging, thoracoscopic biopsies, and fluid analysis—to differentiate benign from malignant or infectious causes.<br /><br />In summary, the lecture integrates landmark studies, guidelines, and recent trial data to support evidence-based approaches in diagnosing and managing complex pleural diseases, underscoring tailored interventions based on disease etiology, severity, and patient status.

Meta Tag

Concept Parapneumonic Effusion

Concept Pleural Infection

Concept Empyema

Concept Malignant Pleural Effusion

Concept Pleural Fluid Analysis

Keywords

parapneumonic effusion

malignant pleural effusion

pleural disease

empyema

thoracentesis

pleurodesis

indwelling pleural catheter

tPA/DNase

pleural biopsy

mesothelioma

Parapneumonic Effusion

Pleural Infection

Empyema

Malignant Pleural Effusion

Pleural Fluid Analysis